02 July 2004
Antibodies against human oxidized low-density lipoprotein (LDL) as markers for human plasma modified lipoproteins
Luminita Radulescu, Camelia Stancu, Felicia AntoheMed Sci Monit 2004; 10(7): BR207-214 :: ID: 11707
Abstract
Background:Recently there has been much interest in the significance and role of antibodies to oxidized LDL (oxLDL) in the plasma of humans and animals with evolving atherosclerosis. The focus in our study was directed on the significance of these antibodies for the pathogenesis and diagnosis of atherosclerosis.
Material/Methods:Antibodies to human in vitro oxidized LDL were generated following the method of Kohler & Milstein and used to detect oxidized LDL in human plasma.Results:Several antibodies to oxLDL were selected for high reactivity against circulating modified LDL. The relationship between antibodies against oxLDL and circulating oxLDL level in human plasma was examined in normal and hyperlipidemic patients. The slight inverse relationship observed between anti-oxLDL antibodies and oxLDL levels in normal patients suggests that anti-oxLDL antibodies have a role in the clearance of oxLDL from circulation.Conclusions:These antibodies can be considered as markers of the pathogenic determinants of atherosclerosis, such as enhanced lipid oxidation, pro-inflammatory stage, and impaired vasodilatation.
Keywords: Angina Pectoris - blood, Antibodies, Monoclonal - chemistry, Antibodies, Monoclonal - immunology, Apolipoprotein A-I - blood, Apolipoproteins B - blood, Autoantibodies - blood, Biological Markers - blood, Blood Glucose - metabolism, Cholesterol - blood, Enzyme-Linked Immunosorbent Assay, Hypertension - blood, Lipoproteins - blood, Lipoproteins, LDL - blood, Lipoproteins, LDL - immunology, Myocardial Ischemia - blood, Spleen - cytology, Triglycerides - blood, Angina Pectoris - blood, Antibodies, Monoclonal - immunology, Apolipoprotein A-I - blood, Apolipoproteins B - blood, Autoantibodies - blood, Biological Markers - blood, Blood Glucose - metabolism, Cholesterol - blood, Enzyme-Linked Immunosorbent Assay, Hypertension - blood, Lipoproteins - blood, Lipoproteins, LDL - immunology, Myocardial Ischemia - blood, Spleen - cytology, Triglycerides - blood
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Clinical Research
Preoperative Blood Transfusion Requirements for Hemorrhoidal Severe Anemia: A Retrospective Study of 128 Pa...Med Sci Monit In Press; DOI: 10.12659/MSM.943126
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952